In patients treated with biologic therapies and with suboptimal disease control, no conclusive agreement was achieved, although the median results showed a trend towards AIT prescription in these profiles ( Table 3 ).
← all excerpts
Allergen immunotherapy for the control of moderate to severe allergic asthma: an evidence-based conjoint analysis to define candidate patient profiles in Spain and Portugal.
1
—
—